News

“From an anti-trust perspective, there are no objections so the transaction can proceed,” said an Actelion spokesman. If the proposed merger is consummated, CoTherix will become an indirect

Orphan drug designation will give the biotech firm European marketing exclusivity for up to 10 years. Orphan status is given to drugs that provide for unmet medical needs

Non steroidal anti-inflammatory drugs such as naproxen and naproxcinod represent the established symptomatic treatment for osteoarthritis. The cardiovascular safety of these drugs has been debated and they are

Researchers suggested the findings could help physicians more accurately predict which tumors will respond to anti-estrogen therapy and improve long-term survival for breast cancer patients. The UC researchers

Typically, the FDA requires two adequate and well-controlled studies to establish substantial evidence of effectiveness. In September 2006, Acorda said the drug improved the walking speed in significantly

This contract was awarded by a supranational organization for Latin America and covers sales in 2007. Supranational organizations are major customers for combination vaccines, which are used in

The trial will be expanded by 30 to 60 participants, an increase of up to 40% from the number originally planned. The company also has earmarked an additional

The documents relate to the drugs Truvada, Viread and Emtriva. Truvada is a combination of Viread and Emtriva. Truvada is for use in combination with other anti-HIV agents

CTI still plans to continue development of Xyotax despite the setback. The drug has already failed three major lung cancer trials. The company said it would submit a